CLINICAL_TRIALS
trial_result
· 2015-12-29
Clinical Trial Update: Intraseasonal Short-time Up-dosing With Alutard SQ Grasses [Phase 3]
Summary
A Phase 3 trial evaluating intraseasonal short-time up-dosing with Alutard SQ Grasses for grass pollen allergy has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ALK-Abelló A/S | Conditions: Allergy | Phase 3 | Status: COMPLETED